A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer
Clinical trial NCT02958852 · COMPLETED
Trial details
- NCT number
- NCT02958852
- Sponsor
- Lund University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-02
- Primary completion
- 2025-01-02
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.